Consumer healthcare giant GlaxoSmithKline Plc has named Iain Mackay as its new chief financial officer.
Mackay is currently HSBC Holdings Plc finance director, a position has has held for the past eight years.
He will join the Panadol and Horlicks maker on January 14, 2019
GSK announced in May that the Company’s CFO, Simon Dingemans, is to retire from the Company in May 2019.
Proven Record
“I’m delighted to welcome Iain to GSK,” said Emma Walmsley, Chief Executive Officer, GSK. “As a proven CFO of a complex, regulated global organisation, he brings tremendous finance experience and will be a great addition to the team. He is a strong leader with a track record of driving cost, cash and capital allocation discipline to deliver strategy.
“These capabilities will be vital as we continue to implement our Innovation, Performance and Trust priorities for the benefit of patients and shareholders.”
Dingemans will continue to be responsible for GSK’s financial governance through to March 2019, the company said with Mackay coming in for a transition period, ahead of him taking the full role of CFO in April.
“On behalf of the Board I welcome Iain to GSK,” said Philip Hampton, Chairman, GSK. “His experience in different sectors and in complex, regulated environments will be valuable to the Board and I look forward to his contributions.”
News by Reuters, edited by ESM. Additional reporting by Stephen Wynne-Jones. Click subscribe to sign up to ESM: European Supermarket Magazine.
